Tag Archives: Marshall McLuhan

Lanham Act: Peer-Review on Trial

Scientific opinion has special protection under the First Amendment, but does that give pharma a free pass to BYOD – build your own dataset – publish a peer-reviewed article based on the data, and then promote it for competitive advantage? The dividing line between fact and fiction becomes increasingly blurry in the age of prolific […]
Posted in Advertising, compliance, Legal, Marketing, Regulatory, Strategy | Also tagged , , , , , , , , | Leave a comment
  • Categories

  • Meta